Reduced blood agmatine level in early-onset schizophrenia

Basit Öğe Kaydı
dc.contributor.authorBaytunca, Burak M.
dc.contributor.authorKalyoncu, Tugba
dc.contributor.authorOzbaran, Burcu
dc.contributor.authorKose, Sezen
dc.contributor.authorOngur, Dost
dc.contributor.authorUzbay, Tayfun
dc.date.accessioned2020-12-01T11:58:40Z
dc.date.available2020-12-01T11:58:40Z
dc.date.issued2020
dc.departmentEge Üniversitesien_US
dc.description.abstract[No abstract available]en_US
dc.description.sponsorshipEge University, Scientific Research ProjectsEge University [15-TIP-066]en_US
dc.description.sponsorshipAuthors would like to thank to Pharm. Selma Ozilhan for her kind contributions for the quantification of plasma agmatine levels in the blood samples. This study was funded by Ege University, Scientific Research Projects (fund number: 15-TIP-066). the authors of the study declare no conflict of interest.en_US
dc.identifier.doi10.1016/j.schres.2020.05.006en_US
dc.identifier.endpage529en_US
dc.identifier.issn0920-9964
dc.identifier.issn1573-2509
dc.identifier.pmid32446703en_US
dc.identifier.scopus2-s2.0-85085753093en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage528en_US
dc.identifier.urihttps://doi.org/10.1016/j.schres.2020.05.006
dc.identifier.urihttps://hdl.handle.net/11454/62079
dc.identifier.volume222en_US
dc.identifier.wosWOS:000579854800086en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.ispartofSchizophrenia Researchen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleReduced blood agmatine level in early-onset schizophreniaen_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu